Stable High Inflammation-Glucose Index Increases Stroke Risk by 76% in Non-Diabetics
New biomarker combining inflammation and glucose metabolism predicts stroke risk better than single measurements in middle-aged adults.
Summary
Researchers tracked 5,973 non-diabetic adults using a new biomarker called the C-reactive protein-triglyceride glucose index (CTI), which combines inflammation and glucose metabolism markers. Only participants with consistently high CTI levels over time had significantly increased stroke risk (76% higher). Those whose levels improved or worsened during the study showed no increased risk, suggesting that sustained metabolic dysfunction rather than temporary spikes drives stroke risk. This longitudinal approach provides better prediction than single measurements.
Detailed Summary
A groundbreaking study reveals that sustained elevation of a novel biomarker combining inflammation and glucose metabolism significantly increases stroke risk in non-diabetic adults. The research introduces important insights about timing and persistence in metabolic health assessment.
Researchers followed 5,973 non-diabetic participants from the China Health and Retirement Longitudinal Study, tracking their C-reactive protein-triglyceride glucose index (CTI) over multiple time points. This composite biomarker reflects both inflammatory status and glucose metabolism efficiency.
Participants were categorized into four groups based on CTI changes: stable low, improved (remitted), worsened (elevated), and stable high. During 3.5 years of follow-up, 310 strokes occurred. Remarkably, only the stable high group showed significantly increased stroke risk—76% higher than the stable low group. Neither temporary improvements nor temporary worsening affected stroke risk.
The findings suggest that sustained metabolic dysfunction, rather than fluctuating levels, drives cardiovascular risk. Mediation analysis revealed that hypertension and dyslipidemia partially explained this association, accounting for 19% and 9% of the effect respectively.
This research challenges the common practice of relying on single biomarker measurements for risk assessment. The longitudinal CTI approach improved stroke prediction beyond conventional risk factors, offering clinicians a more nuanced tool for identifying high-risk patients. For individuals, the study emphasizes that consistent metabolic health maintenance matters more than temporary improvements, highlighting the importance of sustained lifestyle interventions rather than short-term fixes.
Key Findings
- Only sustained high CTI levels increased stroke risk by 76%, not temporary elevations
- Longitudinal CTI tracking improved stroke prediction beyond conventional risk factors
- Hypertension and dyslipidemia partially mediated the CTI-stroke relationship
- Temporary improvements or worsening in CTI did not affect stroke risk
- CTI combines inflammation and glucose metabolism into a single predictive biomarker
Methodology
Prospective cohort study of 5,973 non-diabetic adults from the China Health and Retirement Longitudinal Study with median 3.5-year follow-up. Participants were categorized into four groups based on CTI levels at baseline and wave 3 measurements.
Study Limitations
Summary based on abstract only without access to full methodology details. Study population limited to Chinese adults, potentially limiting generalizability to other populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.